ES2181822T3 - Procedimiento para el analisis de expresion de genes. - Google Patents

Procedimiento para el analisis de expresion de genes.

Info

Publication number
ES2181822T3
ES2181822T3 ES96107942T ES96107942T ES2181822T3 ES 2181822 T3 ES2181822 T3 ES 2181822T3 ES 96107942 T ES96107942 T ES 96107942T ES 96107942 T ES96107942 T ES 96107942T ES 2181822 T3 ES2181822 T3 ES 2181822T3
Authority
ES
Spain
Prior art keywords
procedure
expression analysis
genes expression
analysis
genes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96107942T
Other languages
English (en)
Other versions
ES2181822T5 (es
Inventor
Achim Fischer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sygnis Pharma AG
Original Assignee
Axaron Bioscience AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=7762408&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2181822(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Axaron Bioscience AG filed Critical Axaron Bioscience AG
Publication of ES2181822T3 publication Critical patent/ES2181822T3/es
Application granted granted Critical
Publication of ES2181822T5 publication Critical patent/ES2181822T5/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
    • C12Q1/6855—Ligating adaptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

LA PRESENTE INVENCION TRATA DE UN PROCEDIMIENTO PARA EL ANALISIS GENERAL DE EXPRESION GENICA Y UN PROCEDIMIENTO PARA EL ANALISIS DIFERENCIAL DE LA EXPRESION DE COMPONENTES DE UNA FAMILIA DE GENES.
ES96107942T 1995-05-19 1996-05-17 Procedimiento para el analisis de la expresion de genes. Expired - Lifetime ES2181822T5 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19518505A DE19518505A1 (de) 1995-05-19 1995-05-19 Verfahren zur Genexpressionsanalyse
DE19518505 1995-05-19

Publications (2)

Publication Number Publication Date
ES2181822T3 true ES2181822T3 (es) 2003-03-01
ES2181822T5 ES2181822T5 (es) 2006-05-16

Family

ID=7762408

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96107942T Expired - Lifetime ES2181822T5 (es) 1995-05-19 1996-05-17 Procedimiento para el analisis de la expresion de genes.

Country Status (5)

Country Link
US (1) US5876932A (es)
EP (2) EP1209241A3 (es)
JP (1) JP3150061B2 (es)
DE (2) DE19518505A1 (es)
ES (1) ES2181822T5 (es)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040197774A1 (en) * 1992-11-12 2004-10-07 Michael Wigler Representational approach to DNA analysis
US6379897B1 (en) * 2000-11-09 2002-04-30 Nanogen, Inc. Methods for gene expression monitoring on electronic microarrays
US5712126A (en) * 1995-08-01 1998-01-27 Yale University Analysis of gene expression by display of 3-end restriction fragments of CDNA
AU2264197A (en) * 1996-02-09 1997-08-28 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Restriction display (rd-pcr) of differentially expressed mrnas
ES2163271T3 (es) * 1997-05-13 2002-01-16 Azign Bioscience As Procedimiento para clonar arnm y visualizar transcriptores diferencialmente expresados (dodets).
US6261770B1 (en) 1997-05-13 2001-07-17 Display Systems Biotech Aps Method to clone mRNAs
EP1042504A2 (en) * 1997-12-29 2000-10-11 Genena Ltd. A method for identifying and characterizing cells and tissues
DE19806431C1 (de) * 1998-02-17 1999-10-14 Novartis Ag Neues Verfahren zur Identifikation und Charakterisierung von mRNA-Molekülen
ES2322859T3 (es) * 1998-05-01 2009-06-30 Gen-Probe Incorporated Analizador de diagnostico automatizado.
US8337753B2 (en) * 1998-05-01 2012-12-25 Gen-Probe Incorporated Temperature-controlled incubator having a receptacle mixing mechanism
DE19840731A1 (de) 1998-09-07 2000-03-09 Hoechst Marion Roussel De Gmbh Zwei Farben Differential Display als Verfahren zur Detektion regulierter Gene
DE19849348A1 (de) * 1998-10-26 2000-04-27 Univ Ludwigs Albert Linear Amplification mediated PCR (=LAM PCR)
WO2000029621A2 (en) * 1998-11-16 2000-05-25 Genelabs Technologies, Inc. Method for measuring target polynucleotides and novel asthma biomolecules
US20030190669A1 (en) * 1998-12-30 2003-10-09 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2001066802A1 (en) * 2000-03-09 2001-09-13 Genetag Technology, Inc. SYSTEMS AND METHODS TO QUANTIFY AND AMPLIFY BOTH SIGNALING AND PROBES FOR cDNA CHIPS AND GENES EXPRESSION MICROARRAYS
WO2001009387A1 (en) * 1999-07-29 2001-02-08 Northeastern University Isolation of novel hemapoietic genes by representational difference analysis
WO2003074738A1 (en) * 2000-01-18 2003-09-12 Quantom Dot Corporation Oligonucleotide-tagged semiconductor nanocrystals for microarray and fluorescence in situ hybridization
WO2001054045A2 (en) * 2000-01-21 2001-07-26 Lion Bioscience Ag Data analysis software
WO2001062967A2 (en) * 2000-02-22 2001-08-30 Genena Ltd. A method that compares genomic sequences
US6468749B1 (en) * 2000-03-30 2002-10-22 Quark Biotech, Inc. Sequence-dependent gene sorting techniques
FR2808287B1 (fr) * 2000-04-26 2004-09-17 Ipsogen Methode de mesure quantitative de l'expression des genes
EP1370664B1 (de) * 2001-03-16 2009-12-02 Qiagen GmbH Gegen abbau stabilisierte nukleinsäure
DE10113265B4 (de) 2001-03-16 2018-03-08 Qiagen Gmbh Verwendung einer stabilisierten Nukleinsäure zur Herstellung eines Proteins
EP1463837A4 (en) * 2001-12-21 2006-01-18 Applied Research Systems METHOD FOR IDENTIFICATION OF NEW PROTEINS
DE10208333A1 (de) * 2002-02-27 2003-09-04 Axaron Bioscience Ag Analyse von Nukleinsäure-Fragmentmischungen
US7135292B2 (en) * 2002-06-28 2006-11-14 Harbor Branch Oceanographic Institution, Inc. Analysis and modification of gene expression in marine invertebrate cells
US9487823B2 (en) * 2002-12-20 2016-11-08 Qiagen Gmbh Nucleic acid amplification
US7695723B2 (en) 2002-12-31 2010-04-13 Sygnis Bioscience Gmbh & Co. Kg Methods of treating neurological conditions with hematopoietic growth factors
US7785601B2 (en) 2002-12-31 2010-08-31 Sygnis Bioscience Gmbh & Co. Kg Methods of treating neurological conditions with hematopoietic growth factors
CA2513889A1 (en) * 2003-01-29 2004-08-19 454 Corporation Double ended sequencing
EP1590470A4 (en) * 2003-02-03 2006-09-27 Ge Healthcare Bio Sciences CDNA AMPLIFICATION FOR EXPRESSION PROFILING
US8043834B2 (en) * 2003-03-31 2011-10-25 Qiagen Gmbh Universal reagents for rolling circle amplification and methods of use
WO2005010159A2 (en) * 2003-07-17 2005-02-03 Children's Hospital Medical Center Rolling circle amplification of micro-rna samples
US7919238B2 (en) * 2003-08-08 2011-04-05 Albert J. Wong Method for rapid identification of alternative splicing
ES2379553T3 (es) * 2003-08-29 2012-04-27 Instituto Nacional De Tecnologia Agropecuaria Plantas de arroz que tienen tolerancia aumentada a herbicidas de imidazolinona
US7432082B2 (en) * 2004-03-22 2008-10-07 Basf Ag Methods and compositions for analyzing AHASL genes
EP2290073A3 (en) 2004-05-28 2011-08-31 Asuragen, Inc. Methods and compositions involving microRNA
CN101031646B (zh) * 2004-07-30 2013-09-25 巴斯夫农业化学产品公司 抗除草剂的向日葵植物、编码抗除草剂的乙酰羟酸合酶大亚基蛋白的多核苷酸和使用方法
CA2857878A1 (en) 2004-11-12 2006-12-28 Asuragen, Inc. Methods and compositions involving mirna and mirna inhibitor molecules
MX2007010552A (es) * 2005-03-02 2009-02-19 Inst Nac De Tecnologia Agropec Plantas de arroz resistentes a herbicidas, polinucleotidos que codifican proteinas de subunidad grande de acido acetohidroxi sintasa resistentes a herbicidas, y sus metodos de uso.
US8309303B2 (en) * 2005-04-01 2012-11-13 Qiagen Gmbh Reverse transcription and amplification of RNA with simultaneous degradation of DNA
JP5265356B2 (ja) * 2005-07-01 2013-08-14 ビーエーエスエフ ソシエタス・ヨーロピア 除草剤耐性ヒマワリ植物、除草剤耐性のアセトヒドロキシ酸シンターゼ大サブユニットタンパク質をコードするポリヌクレオチド、及び使用方法
EP1762627A1 (de) 2005-09-09 2007-03-14 Qiagen GmbH Verfahren zur Aktivierung einer Nukleinsäure für eine Polymerase-Reaktion
US9012184B2 (en) * 2006-02-08 2015-04-21 Illumina Cambridge Limited End modification to prevent over-representation of fragments
DE102006020885A1 (de) * 2006-05-05 2007-11-08 Qiagen Gmbh Einführung von Sequenzelementen in Nukleinsäuren
JP2010510964A (ja) 2006-09-19 2010-04-08 アシュラジェン インコーポレイテッド 治療的介入の標的としての、ｍｉＲ−１５、ｍｉＲ−２６、ｍｉＲ−３１、ｍｉＲ−１４５、ｍｉＲ−１４７、ｍｉＲ−１８８、ｍｉＲ−２１５、ｍｉＲ−２１６、ｍｉＲ−３３１、ｍｍｕ−ｍｉＲ−２９２−３ｐによって調節される遺伝子および経路
WO2008036765A2 (en) 2006-09-19 2008-03-27 Asuragen, Inc. Micrornas differentially expressed in pancreatic diseases and uses thereof
UA108733C2 (uk) 2006-12-12 2015-06-10 Толерантна до гербіциду рослина соняшника
US10017827B2 (en) 2007-04-04 2018-07-10 Nidera S.A. Herbicide-resistant sunflower plants with multiple herbicide resistant alleles of AHASL1 and methods of use
US8258111B2 (en) 2008-05-08 2012-09-04 The Johns Hopkins University Compositions and methods related to miRNA modulation of neovascularization or angiogenesis
WO2010039189A2 (en) * 2008-09-23 2010-04-08 Helicos Biosciences Corporation Methods for sequencing degraded or modified nucleic acids
EP2354243A1 (en) * 2010-02-03 2011-08-10 Lexogen GmbH Complexity reduction method
EP3214174B1 (en) 2010-03-04 2019-10-16 InteRNA Technologies B.V. A mirna molecule defined by its source and its diagnostic and therapeutic uses in diseases or conditions associated with emt
NZ605420A (en) 2010-07-06 2015-02-27 Interna Technologies Bv Mirna and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated braf pathway
CA2817882C (en) 2010-11-17 2022-08-23 Asuragen, Inc. Mirnas as biomarkers for distinguishing benign from malignant thyroid neoplasms
EP2474617A1 (en) 2011-01-11 2012-07-11 InteRNA Technologies BV Mir for treating neo-angiogenesis
MX2013009863A (es) 2011-02-28 2013-12-06 Univ Iowa Res Found Cambios de la hormona anti-mulleriana en el embarazo y prediccion de sexo y de resultados adversos en el embarazo.
WO2013040251A2 (en) 2011-09-13 2013-03-21 Asurgen, Inc. Methods and compositions involving mir-135b for distinguishing pancreatic cancer from benign pancreatic disease
PL2756098T3 (pl) 2011-09-16 2018-12-31 Lexogen Gmbh Sposób wytwarzania biblioteki cząsteczek kwasów nukleinowych
US20130157884A1 (en) 2011-10-26 2013-06-20 Asuragen, Inc. Methods and compositions involving mirna expression levels for distinguishing pancreatic cysts
EP2771487A1 (en) 2011-10-27 2014-09-03 Asuragen, INC. Mirnas as diagnostic biomarkers to distinguish benign from malignant thyroid tumors
US20150152499A1 (en) 2012-07-03 2015-06-04 Interna Technologies B.V. Diagnostic portfolio and its uses
US20140100124A1 (en) 2012-10-04 2014-04-10 Asuragen, Inc. Diagnostic mirnas for differential diagnosis of incidental pancreatic cystic lesions
US9944992B2 (en) 2013-03-15 2018-04-17 The University Of Chicago Methods and compositions related to T-cell activity
US9868992B2 (en) 2013-03-15 2018-01-16 Baylor Research Institute Tissue and blood-based miRNA biomarkers for the diagnosis, prognosis and metastasis-predictive potential in colorectal cancer
US9758835B2 (en) 2013-03-15 2017-09-12 Baylor Research Institute Ulcerative colitis (UC)-associated colorectal neoplasia markers
US10435736B2 (en) * 2014-12-18 2019-10-08 Mgi Tech Co., Ltd. Target region enrichment method based on multiplex PCR, and reagent
EP3704250A1 (en) 2017-11-03 2020-09-09 InteRNA Technologies B.V. Mirna molecule, equivalent, antagomir, or source thereof for treating and/or diagnosing a condition and/or a disease associated with neuronal deficiency or for neuronal (re)generation
EP3714053B1 (en) 2017-11-22 2025-12-31 The University of Chicago CHEMICALLY DEPENDENT PROBE EVALUATION OF PROTEIN ACTIVITY AND ITS USES
US20220205035A1 (en) 2019-04-05 2022-06-30 Board Of Regents, The University Of Texas System Methods and applications for cell barcoding
WO2020210521A2 (en) 2019-04-12 2020-10-15 The Regents Of The University Of California Compositions and methods for increasing muscle mass and oxidative metabolism
WO2024028794A1 (en) 2022-08-02 2024-02-08 Temple Therapeutics BV Methods for treating endometrial and ovarian hyperproliferative disorders
WO2025248505A1 (en) 2024-05-31 2025-12-04 Wayne State University Methods for treating endometrial and ovarian hyperproliferative disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683195A (en) * 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
JP2843675B2 (ja) * 1992-03-11 1999-01-06 ダナ−ファーバー・キャンサー・インスチチュート・インコーポレーテッド メッセンジャーｒｎａの同定、単離およびクローニング
DE69621507T2 (de) * 1995-03-28 2003-01-09 Japan Science And Technology Corp., Kawaguchi Verfahren zur molekularen Indexierung von Genen unter Verwendung von Restriktionsenzymen

Also Published As

Publication number Publication date
JP3150061B2 (ja) 2001-03-26
EP0743367A2 (de) 1996-11-20
JPH08308598A (ja) 1996-11-26
EP1209241A2 (de) 2002-05-29
EP0743367B1 (de) 2002-08-07
DE59609524D1 (de) 2002-09-12
DE19518505A1 (de) 1996-11-21
ES2181822T5 (es) 2006-05-16
US5876932A (en) 1999-03-02
EP1209241A3 (de) 2004-01-07
EP0743367A3 (de) 2000-09-06
EP0743367B2 (de) 2005-10-26

Similar Documents

Publication Publication Date Title
ES2148345T3 (es) Composicion farmaceutica con ciclosporina a, un derivado de vitamina e y un emulsionante.
ES2178093T3 (es) Derivados de epotilon y su preparacion.
ATE114723T1 (de) Organismus als träger für ''single chain antibody domain (scad)''.
FI953812A7 (fi) Kohdistettujen geenien säädelty transkriptio ja muita biologisia toimintoja
DK1489082T3 (da) Mellemprodukter
ES2170102T3 (es) Aminociclohexilesteres y utilizacion de los mismos.
ES2139552T1 (es) Moduladores de la transcripcion regulado por tetraciclinas.
NO20002979L (no) Undersøkelse av human papillomavirus-relatert sykdom
DK0938308T3 (da) Antiparasitiske midler
DE59609524D1 (de) Verfahren zur Genexpressionsanalyse
ATE419268T1 (de) Haemasterlin analoge
WO1999016791A3 (en) Compounds and methods for regulating cell adhesion
ES2142512T3 (es) Nuevas substancias odoriferas.
AU1166199A (en) Methods for identifying the toxic/pathologic effect of environmental stimuli on gene transcription
BR9812222A (pt) Preparação farmacêutica separada de complexo de protrombina, preparação diagnóstica, e, utilização de uma preparação
DK0792373T3 (da) Scintillations-tilnærmelsesassay for N-acetylgalactosaminltransferase-aktivitet
BR9710919A (pt) Proteina purificada sr-p70
AR004169A1 (es) Forma de solvato alcoholico de 2-metil-4-(4-metil-1-piperacinil)-10 h-tieno(2,3-b)(1,5) benzodiacepina (olanzapina)
AU7296696A (en) Deodorising formulations containing cationic biopolymers, aluminium chlorhydrate and esterase inhibitors
DE69637243D1 (de) Atelocollagen enthaltende gen-zusammensetzungen
AU1278600A (en) Novel therapeutic application of nicergoline
NO973366L (no) Fremgangsmåte for behandling av multippel sklerose
NO20005548L (no) Mykobakterieinhibitorer
ES2186963T3 (es) Aislados de rizobacterias para su utilizacion contra hongos del suelo fitopatogenos y procedimiento para la utilizacion de aislados de rizobacterias.
ZA967590B (en) Glucocorticoid enhancement of gene expression.